Supplementary Figure 9 from A PD-L1/CD3 Bispecific Antibody Enhances the Antitumor Effects of Regorafenib against Colon Cancer
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Figure 9 confirms abscopal tumor effects after local REG/bsAb treatment.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4412843806
